CLASS II Device recall · Reported 9 Mar 2022 · FDA Enforcement Report

Titanium Mpj (Toe Implant) Toe Joint Titanium Npc SM, Part ID recalled

BioPro is recalling Titanium Mpj (Toe Implant) Toe Joint Titanium Npc SM, Part ID 16813, distributed nationwide in the US. The recall was initiated on 1 Feb 2022 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLot Number: 128667; UDI: 00810012480086

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-0682-2022
FDA event ID
89605
Recalling firm
BioPro, Port Huron, MI
Classification
Class II
Status
Terminated
Recall initiated
1 Feb 2022
FDA classified
28 Feb 2022
Reported
9 Mar 2022
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Labeling Errors

Timeline

1 Feb 2022Recall initiated by company
28 Feb 2022Classified by FDA+27 days
9 Mar 2022Published in enforcement report+9 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

There is an incorrect statement regarding MR Compatibility in the BioPro Titanium MPJ implant IFU (IFU BP102303 rev 05) and patient implant cards (22266 rev 00) which indicates that the BioPro MPJ Implant has been tested for safety and compatibility in the MR Environment and is MR Conditional. MR Testing has not been conducted on the titanium version of the MPJ.

Product as listed by the FDA

Titanium MPJ (Toe Implant) TOE JOINT TITANIUM NPC SM, Part ID 16813

Where it was distributed

US Nationwide distribution in the states of CT, KY, NM, PA, TN, and SD.

Nationwide ConnecticutKentuckyNew MexicoPennsylvaniaSouth DakotaTennessee

Questions about this recall

Why was it recalled?

There is an incorrect statement regarding MR Compatibility in the BioPro Titanium MPJ implant IFU (IFU BP102303 rev 05) and patient implant cards (22266 rev 00) which indicates that the BioPro MPJ Implant has been tested for safety and compatibility in the MR Environment and is MR Conditional. MR Testing has not been conducted on the titanium version of the MPJ.

Which lots are affected?

Lot Number: 128667; UDI: 00810012480086

Where was it sold?

US Nationwide distribution in the states of CT, KY, NM, PA, TN, and SD.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

Other products in this recall event

9 other products · FDA event 89605

This product is part of a recall event; the main page for the event is Titanium Mpj (Toe Implant) Toe Joint Titanium PC M/L, Part ID recalled.

More recalls from BioPro

All 37

Other Other Medical Devices recalls

All 13,908